HK Stock MarketDetailed Quotes
00858 EXTRAWELL PHAR
- 0.055
- +0.008+17.02%
Market Closed Dec 16 16:08 CST
131.45MMarket Cap0.74P/E (TTM)
0.067High0.053Low6.23MVolume0.054Open0.047Pre Close354.72KTurnover0.26%Turnover RatioLossP/E (Static)2.39BShares0.07452wk High0.11P/B131.45MFloat Cap0.02652wk Low--Dividend TTM2.39BShs Float3.920Historical High--Dividend LFY29.79%Amplitude0.010Historical Low0.056Avg Price10000Lot Size--Div YieldTTM--Div Yield LFY
About EXTRAWELL PHAR Company
Jingyou Pharmaceutical Holdings Limited is a limited company incorporated in Bermuda. Its shares are listed on the main board of the Hong Kong Stock Exchange Limited. The Company is an investment holding company. The main business characteristics of its subsidiaries include promoting and distributing pharmaceuticals to Chinese customers; developing, manufacturing and selling pharmaceutical products in China; engaging in commercial development and R&D of gene-related technology; and developing and commercializing oral insulin products (through the interests of an associated company).
Company Profile
Symbol00858
Company NameEXTRAWELL PHAR
ISINBMG3285Q1134
Listing DateMar 10, 1999
Issue Price1.00
Shares Offered50.00M share(s)
Registered AddressBermuda
Chairmanyi xie
Secretaryxiujuan wang
Company CategoryOther
Registered OfficeClarendon House 2 Church Street Hamilton HM11 Bermuda
Head Office and Principal Place of BusinessRoom 2206-08, 22nd floor, Tak Hong Building, Taikoo Place, 979 King's Road, Quarry Bay, Hong Kong
Fiscal Year Ends03-31
Employees162
MarketHong Kong motherboard
Phone+852 2110 6922
Fax+852 2856 3139
Emailinvestor@extrawell.com.hk
Websitehttp://www.extrawell.com.hk
Business Jingyou Pharmaceutical Holdings Co., Ltd. is an investment holding company mainly engaged in the development, manufacture and sale of pharmaceuticals. The company mainly operates through three divisions. The manufacturing division is engaged in the development, manufacture and sale of pharmaceutical products. Its homemade products include Transfer Factor Oral Solution, Guanxin Ke, and Zhoubang. The Trade Division is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Meriba and currently available. The Gene Development Division is engaged in commercial development and R&D of gene-related technology.
Company Executives
- Name
- Position
- Salary
- yi xie
- Chairman of the Board, CEO, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
- 1.39M
- yong cheng
- Executive Director, Deputy Chief Executive
- 713.00K
- yi lou
- Executive Director
- 557.00K
- xiujuan wang
- Executive Director, Authorized Representative, Company Secretary
- 940.00K
- yi guo
- Executive Director
- --
- linhu fang
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Chairman, Nomination Committee Members
- 70.00K
- song jin
- Independent Non-Executive Director, Nomination Committee Members, Remuneration Committee Members, Audit Committee Members
- 70.00K
- li ceng
- Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
- --
- youlu gong
- General Manager of Jilin Jingyou Changbaishan Pharmaceutical Co., Ltd., General Manager of Changchun Jingyou Pharmaceutical Co., Ltd.
- --
- wenda huang
- Financial Director of Changchun Jingyou and Jilin Jingyou
- --
Heat List
HK
Overall
Symbol
Price
% Chg
No Data